Main Subjects = Hepatology
Biomarkers in Liver Disease: From Diagnosis to Prognosis

Volume 10, Issue 4, December 2020, Pages 332-334

Heba F Pasha


Serum MiRNA-122 as a Diagnostic Marker in HCV Related Liver Cirrhosis

Volume 10, Issue 4, December 2020, Pages 335-345

Tahia M Ahmed; Ebtesam I Ahmad; Salah E Ibrahim; Maysaa A Saeed


HCC Incidence in DAAs-Treated and Untreated Egyptian HCV-Infected Patients

Volume 10, Issue 4, December 2020, Pages 346-355

Mohammed Alaa El-Din Nouh; Mahmoud Mohammed Moawad Sera; Ahmed Ragab El-Gazzarah


Predictive Value of Red Cell Volume Distribution Width-to-Platelet Ratio in Staging Liver Fibrosis in Chronic HCV-Infected Patients

Volume 10, Issue 4, December 2020, Pages 356-363

Ali Saad Nada; Nashwa Shebl; Ahmed Ragab El-Gazzarah; Warda Othman


Prevalence and Predictors of Occult Hepatitis C Infection in High-Risk Egyptian Populations

Volume 10, Issue 4, December 2020, Pages 364-372

Mohammad M Sallam; Hanan S Ahmed; Hanan H Soliman; Sameh M Abdel Monem; Essam Abdel Wahab


Presepsin and Resistin as Diagnostic Markers for Bacterial Infection in Patients with Decompensated Cirrhosis

Volume 10, Issue 4, December 2020, Pages 389-396

Mahmoud Ahmed Sharafeddin; Amany Mohammed Abd Allah; Ahmed Abdelrahman


Microwave Ablation and/or Transcatheter Arterial Chemo-embolization in the Treatment of Hepatocellular Carcinoma

Volume 10, Issue 4, December 2020, Pages 407-416

Sara R Abozaid; Mustafa H Elshamy; Ahmed A Alazim; Soha A Elhawari


Cardiac Changes in Cirrhotic Patients

Volume 10, Issue 3, September 2020, Pages 249-256

Sameh M Abdel Monem; Mostafa Moaz; Hisham S Roshdy; Kamal Amer


Assessment of Thyroid Dysfunction in Patients with Chronic Hepatitis C Virus Related Liver Diseases

Volume 10, Issue 3, September 2020, Pages 257-263

Islam Mustafa Ahmed Hassan; Nader Attia Elnemr; Mohamed Ahmed Ibrahim Aboelmagd; Fatma Rageh Moussa Mohamed


Evaluation of Golgi Protein-73 as a Tumor Marker in Patients with Hepatocellular Carcinoma

Volume 10, Issue 3, September 2020, Pages 294-300

Naglaa El-Toukhy; Mona Youssef Abd-Alrahman; Hesham A Eissa


Efficacy of Sofosbuvir and Ledipasvir in Comparison to Sofosbuvir and Daclatasvir in Management of Egyptian Chronic Hepatitis C Patients

Volume 10, Issue 2, June 2020, Pages 163-173

Israa Alaa Nouh; Adila Mostafa; Eman Elsheimy; Sameh Sief; Basem Eysa


Cost-Effectiveness of HCV Core Antigen versus PCR for Monitoring Treatment Response in DAAS-Treated Egyptian Patients

Volume 10, Issue 2, June 2020, Pages 174-182

Mohammed Alaa EL-Din Nouh; Mohamed Gamal Elhelbawy; Mohammed Abdel Badie Mohammed Soliman; Ahmed Ragab El-Gazzarah


Golgi Protein 73 as a Diagnostic Tool for Hepatocellular Carcinoma in Cirrhotic Hepatitis C Patients

Volume 10, Issue 2, June 2020, Pages 192-199

Basma Badreldin Hasan; Ahmed Gaber; Seham Ahmed Omar


The Diagnostic role of Soluble (sAxl) Level in Patients with Hepatocellular Carcinoma compared to Alpha-fetoprotein

Volume 10, Issue 2, June 2020, Pages 213-225

Ayman M El Lehleh; Nasser M Abd Elbary; Reham Elzayat; Ahmed R El-Gazzarah; Naglaa S Elabd


Ascitic non-HDL-C/HDL-C ratio:a novel prognostic marker in liver cirrhosis

Volume 10, Issue 1, March 2020, Pages 1-9

Marwa M Esawy; Marwa A Shabana; Elsayed S Abd elbaser; Hany M Elsadek


Evaluation of HCV-associated Hepatocellular Carcinoma based on Alpha-fetoprotein levels

Volume 10, Issue 1, March 2020, Pages 10-15

Elsayed S Abd elbaser; Marwa A Shabana; Abeer Hussein Abdelkader; Samir Abdel-Azim Afifi


Is Glypican-3 useful Diagnostic Marker that Distinguishes Hepatocellular Carcinoma from Liver Cirrhosis?

Volume 10, Issue 1, March 2020, Pages 32-38

Seham A Omar; Basma Badreldin Hasan; Wael Gamal; Adel Ahmed Hasan


Study of the Relation between Endothelial Nitric Oxide Synthase G894T Gene Variants and Occurrence of Type II Hepatorenal Syndrome

Volume 10, Issue 1, March 2020, Pages 39-49

Hossam I Mohammed; Safaa I Tayel; Mostafa M El Nimer; Naglaa S Elabd